Tot Biopharm International Co

Tot Biopharm International Co. reports its carbon emissions for the pharmaceutical preparation manufacturing sector. For the reporting year 2023, no specific emissions data was disclosed.

In 2022, Tot Biopharm International Co. reported combined Scope 1 and Scope 2 emissions of approximately 11,431,000 kg CO2e. Scope 1 emissions for that year were approximately 4,516,000 kg CO2e, and Scope 2 emissions were approximately 6,915,000 kg CO2e.

For 2021, the company reported combined Scope 1 and Scope 2 emissions totalling approximately 15,014,000 kg CO2e. This comprised approximately 4,722,000 kg CO2e of Scope 1 emissions and approximately 10,291,000 kg CO2e of Scope 2 emissions.

In 2020, Tot Biopharm International Co. reported combined Scope 1 and Scope 2 emissions of approximately 14,769,000 kg CO2e, with Scope 1 emissions at approximately 5,075,000 kg CO2e and Scope 2 emissions at approximately 9,693,000 kg CO2e.

The previous year, 2019, saw combined Scope 1 and Scope 2 emissions of approximately 11,319,000 kg CO2e, consisting of approximately 3,562,000 kg CO2e in Scope 1 and approximately 7,757,000 kg CO2e in Scope 2.

The available data indicates that Tot Biopharm International Co. has not yet disclosed Scope 3 emissions, with "purchased goods and services" being a noted missing data point. There is no information available regarding specific climate reduction targets or initiatives, nor is there any indication that emissions data is cascaded from a parent organisation.